@Article{Wysocki2009,
journal="Archives of Medical Science",
issn="1734-1922",
volume="5",
number="2",
year="2009",
title="Cardiotoxicity of 5-fluorouracil in a young colorectal cancer patient \– case report and review of literature",
abstract="Pyrimidine analogues such as 5-fluorouracil (5-FU) are widely used in adjuvant and palliative treatment of various solid tumours. However, their administration may be associated with severe adverse events such as myelosuppression, mucositis or cardiotoxicity. Cardiotoxicity is a relatively rare event but its fatal outcomes occur at a rate of 2.2-13.3%. Since 5-fluorouracil is widely used in medical oncology, cardiotoxicity associated with its administration may significantly impair treatment of patients with cancers sensitive to pyrimidine analogues. This article reviews fluoropyrimidine-associated cardiotoxicity and presents a case report of a young woman who experienced this complication during 5-fluorouracil treatment.",
author="Wysocki, Piotr J.
and Hutka, Małgorzata",
pages="277--280",
url="https://www.termedia.pl/Cardiotoxicity-of-5-fluorouracil-in-a-young-colorectal-cancer-patient-8211-case-report-and-review-of-literature,19,12887,1,1.html"
}